Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-01-01 @ 11:47 PM
Study NCT ID:
NCT04272151
Status:
UNKNOWN
Last Update Posted:
2023-04-18
First Post:
2020-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma
Sponsor:
Chongqing Precision Biotech Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-02-13
First Submit QC Date:
None
Study First Post Date:
2020-02-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-16
Last Update Post Date:
2023-04-18
Last Update Post Date Type:
ACTUAL